Low GI Diet Effects on Non-Alcoholic Fatty Liver Disease
NCT ID: NCT04415632
Last Updated: 2021-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
16 participants
INTERVENTIONAL
2020-12-10
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will be allocated randomly to a 2-week either high GI (HGI) or low GI (LGI) diet followed by a 4-week wash-out period and then the LGI or HGI diet, opposite to the first 2-weeks (N= 16).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating the Effects of a High GI Versus a Low GI Diet on Hepatic Metabolism and Satiety Levels in Healthy Subjects
NCT02482558
Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease
NCT04369521
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
NCT05268042
Effects of Low Fat Versus Low Carbohydrate Diets on Energy Metabolism
NCT03878108
Westlake N-of-1 Trials for Macronutrient Intake
NCT04125602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LGI Diet
low glycemic index diet
low glycemic index diet
• Three-day cycle menu of LGI diet will be designed and supplied to each participant in an amount designed to meet their estimated energy requirements. The percentage energy from protein, fat and carbohydrate will be the same in the two diets. Each diet period of the trial will last for two weeks.
HGI Diet
High glycemic index diet
High glycemic index diet
Three-day cycle menu of HGI diet will be designed and supplied to each participant in an amount designed to meet their estimated energy requirements. The percentage energy from protein, fat and carbohydrate will be the same in the two diets. Each diet period of the trial will last for two weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
low glycemic index diet
• Three-day cycle menu of LGI diet will be designed and supplied to each participant in an amount designed to meet their estimated energy requirements. The percentage energy from protein, fat and carbohydrate will be the same in the two diets. Each diet period of the trial will last for two weeks.
High glycemic index diet
Three-day cycle menu of HGI diet will be designed and supplied to each participant in an amount designed to meet their estimated energy requirements. The percentage energy from protein, fat and carbohydrate will be the same in the two diets. Each diet period of the trial will last for two weeks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Detected NAFLD by CAP-FibroScan™ \>288dB/m or by MRI-PDFF) \> 5% fat of liver weight.
* Body mass index ≥ 25 kg/m2
* Have current moderate to high GI diet intake of ≥ 60 (Assessed from a completed 7-day food diary).
* Abdominal obesity (Waist circumference \> 102 cm for males and \> 88 cm for females)
* Able to give informed consent.
* Able to undergo MRI/S and CAP-FibroScan™.
Exclusion Criteria
* Perimenopausal (irregular periods) women.
* Participants with other liver abnormalities.
* Participants with history of gastrointestinal surgeries, depression, eating disorders or difficulties.
* Participants using pharmacologic agents for obesity or NAFLD.
* Participants with type 1 diabetes.
* Participants with type 2 diabetes on second line medications (eg GLP-1 analogues, sulfonylureas).
* Participation in any other trial in the last 3 months.
* Participants on any special diets (e.g. vegetarians).
* Intolerance to foods included in the diet plan.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NIHR Nottingham Clinical Research Facility Nottingham Digestive Diseases Centre
Nottingham, Nottinghamshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Al-Awadi A, Grove J, Taylor M, Valdes A, Vijay A, Bawden S, Gowland P, Aithal G. Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation. BMJ Open. 2021 Oct 7;11(10):e045802. doi: 10.1136/bmjopen-2020-045802.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
262245
Identifier Type: OTHER
Identifier Source: secondary_id
19/EM/0291
Identifier Type: OTHER
Identifier Source: secondary_id
19042
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.